|
TSX Venture Exchange, NowVertical Group Inc., View from the C-Suite
|
|
NowVertical Group Inc.
|
Mar 11, 2022 10:30AM
|
|
VALEO PHARMA ADDS PHARMACEUTICAL INDUSTRY VETERAN KYLE STEIGER TO LEADERSHIP TEAM
|
|
Valeo Pharma Inc.
|
Aug 30, 2022 07:00AM
|
|
Valeo Pharma Announces Additional Provincial Reimbursement Coverage for Redesca™ and Redesca HP™
|
|
Valeo Pharma Inc.
|
Jul 13, 2021 07:00AM
|
|
Valeo Pharma Announces Listing Of Convertible Debentures On TSX
|
|
Valeo Pharma Inc.
|
Apr 19, 2022 07:00AM
|
|
Valeo Pharma Announces Listing To The Toronto Stock Exchange
|
|
Valeo Pharma Inc.
|
Mar 28, 2022 07:00AM
|
|
Valeo Pharma Announces Record Revenues and Gross Margins for its Third Quarter 2021
|
|
Valeo Pharma Inc.
|
Sep 22, 2021 04:54PM
|
|
VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS, APPOINTMENTS AND OPTIONS AND RSU GRANTS
|
|
Valeo Pharma Inc.
|
Apr 28, 2022 08:51AM
|
|
Valeo Pharma Closes $11.5 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option
|
|
Valeo Pharma Inc.
|
Jun 29, 2021 09:39AM
|
|
Valeo Pharma Closes Previously Announced Upsized $15 Million Bought Deal Private Placement And Concurrent $10 Million Private Placement...
|
|
Valeo Pharma Inc.
|
Dec 09, 2021 02:51PM
|
|
VALEO PHARMA CLOSES US$40 MILLION NON-DILUTIVE FINANCING FROM SAGARD HEALTHCARE PARTNERS
|
|
Valeo Pharma Inc.
|
Aug 02, 2022 08:30AM
|
|
Valeo Pharma Completes Negotiations with Pan-Canadian Pharmaceutical Alliance for Enerzair® Breezhaler® and Atectura® Breezhaler®
|
|
Valeo Pharma Inc.
|
Oct 05, 2021 07:00AM
|
|
VALEO PHARMA ENTERS INTO AN AGREEMENT FOR OPHTHALMIC PRODUCTS, PrXIIDRA® AND PrSIMBRINZA®, IN CANADA
|
|
Valeo Pharma Inc.
|
Aug 02, 2022 07:00AM
|
|
Valeo Pharma Enters Into Canadian Commercial Services Agreement With Veru For Sabizabulin In Hospitalized Adult Patients With Covid-19 At High Risk...
|
|
Valeo Pharma Inc.
|
Sep 14, 2022 07:00AM
|
|
VALEO PHARMA ENTERS INTO LICENSE AGREEMENT WITH KALÉO FOR THE CANADIAN RIGHTS TO ALLERJECT®
|
|
Valeo Pharma Inc.
|
Aug 02, 2022 07:45AM
|
|
Valeo Pharma Inc. Opens the Market
|
|
Valeo Pharma Inc.
|
May 09, 2022 11:00AM
|
|
Valeo Pharma Obtains Listings for Redesca from Two GPO Representing 700 Hospitals and Healthcare Facilities Across Canada
|
|
Valeo Pharma Inc.
|
Oct 13, 2021 07:00AM
|
|
Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® And Atectura® Breezhaler® In Ontario, Manitoba And New Brunswick
|
|
Valeo Pharma Inc.
|
Feb 24, 2022 08:34AM
|
|
Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® And Atectura® Breezhaler® In Quebec And Nova Scotia
|
|
Valeo Pharma Inc.
|
Dec 15, 2021 07:00AM
|
|
Valeo Pharma Obtains Public Reimbursement for Redesca™ and Redesca Hp™ in Quebec
|
|
Valeo Pharma Inc.
|
Nov 15, 2021 08:21AM
|
|
Valeo Pharma Reports Its First Quarter 2022 Results And Highlights
|
|
Valeo Pharma Inc.
|
Mar 24, 2022 05:41PM
|
